Asia Pacific Primary Care Poc Diagnostics Market Size & Outlook

The primary care poc diagnostics market in Asia Pacific is expected to reach a projected revenue of US$ 4,573.3 million by 2030. A compound annual growth rate of 4.9% is expected of Asia Pacific primary care poc diagnostics market from 2025 to 2030.
Revenue, 2024 (US$M)
$3,415.3
Forecast, 2030 (US$M)
$4,573.3
CAGR, 2025 - 2030
4.9%
Report Coverage
Asia Pacific

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific primary care poc diagnostics market, 2018-2030 (US$M)

Asia Pacific primary care poc diagnostics market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific primary care poc diagnostics market highlights

  • The Asia Pacific primary care poc diagnostics market generated a revenue of USD 227.4 million in 2024.
  • The market is expected to grow at a CAGR of 5.6% from 2025 to 2030.
  • In terms of segment, infectious diseases was the largest revenue generating product in 2024.
  • Cancer Marker is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, India is expected to register the highest CAGR from 2025 to 2030.

Asia Pacific data book summary

Market revenue in 2024USD 227.4 million
Market revenue in 2030USD 323.3 million
Growth rate5.6% (CAGR from 2025 to 2030)
Largest segmentInfectious diseases
Fastest growing segmentCancer Marker
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationGlucose Testing, Hb1Ac Testing, Coagulation, Fertility/Pregnancy, Infectious Diseases, Cardiac Markers, Thyroid Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug Abuse Testing, Autoimmune Disease, Urinalysis/Nephrology
Key market players worldwideRoche Holding AG ADR, BD, Danaher Corp, Abbott Laboratories, BioMerieux SA, Siemens Healthineers AG ADR, QuidelOrtho Corp, Thermo Fisher Scientific Inc, Johnson & Johnson Services, Inc., Becton Dickinson & Co, OraSure Technologies Inc

Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 17.3% of the global primary care poc diagnostics market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 323.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Primary Care POC Diagnostics Market Companies

Name Profile # Employees HQ Website
Johnson & Johnson Services, Inc. View profile - - -
OraSure Technologies Inc View profile 638 220 East First Street, Bethlehem, PA, United States, 18015 https://www.orasure.com
BD View profile 10001+ Franklin Lakes, New Jersey, United States, North America https://www.bd.com
QuidelOrtho Corp View profile 7100 9975 Summers Ridge Road, San Diego, CA, United States, 92121 https://www.quidelortho.com
Danaher Corp View profile 63000 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 https://www.danaher.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com
BioMerieux SA View profile 13982 Marcy l’Etoile, Lyon, France, 69280 http://www.biomerieux.com
Becton Dickinson & Co View profile 73000 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 https://www.bd.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com
Roche Holding AG ADR View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com

Asia Pacific primary care poc diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to primary care poc diagnostics market will help companies and investors design strategic landscapes.


Infectious diseases was the largest segment with a revenue share of 31.05% in 2024. Horizon Databook has segmented the Asia Pacific primary care poc diagnostics market based on glucose testing, hb1ac testing, coagulation, fertility/pregnancy, infectious diseases, cardiac markers, thyroid stimulating hormone, hematology, primary care systems, decentralized clinical chemistry, feces, lipid testing, cancer marker, blood gas/electrolytes, ambulatory chemistry, drug abuse testing, autoimmune disease, urinalysis/nephrology covering the revenue growth of each sub-segment from 2018 to 2030.


Point of care tests is gaining rapid adoption attributive to associated advantages with its usage which include fast, easy and mobile diagnosis and self-monitoring. These products offer diagnosis and monitoring for patients at hospitals, health assessment centers, clinics, home healthcare.

Development of healthcare infrastructure coupled with higher prevalence of chronic and targeted diseases like diabetes and cancer along with infectious conditions including HIV, syphilis, RSV, and others are expected to drive the market in Asia Pacific countries.

Furthermore, rise in adoption of miniaturized models and measures taken for reduction in stay at hospitals and clinics are expected to fuel the demand for POC products. Adoption of POC diagnostics in operation theaters, emergency rooms, intensive care units, path labs and hospitals is expected to rise owing to the early and efficient results.

Reasons to subscribe to Asia Pacific primary care poc diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific primary care poc diagnostics market databook

  • Our clientele includes a mix of primary care poc diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific primary care poc diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific primary care poc diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific primary care poc diagnostics market size, by country, 2018-2030 (US$M)

Asia Pacific Primary Care POC Diagnostics Market Outlook Share, 2024 & 2030 (US$M)

Asia Pacific primary care poc diagnostics market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online